about
sameAs
Optimal duration of androgen deprivation therapy following radiation therapy in intermediate- or high-risk nonmetastatic prostate cancer: A systematic review and metaanalysisAddition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroupsAndrogenic suppression combined with radiotherapy for the treatment of prostate adenocarcinoma: a systematic reviewCost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer.Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis.Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review.Prevention strategies for chemotherapy-induced hand-foot syndrome: a systematic review and meta-analysis of prospective randomised trials.Cardiovascular events associated with androgen deprivation therapy in patients with prostate cancer: a systematic review and meta-analysis.Neoadjuvant endocrine therapy for resectable breast cancer: A systematic review and meta-analysis.The impact of complete chemotherapy stop on the overall survival of patients with advanced colorectal cancer in first-line setting: A meta-analysis of randomized trials.Second brazilian consensus on the treatment of advanced prostate cancer - a SBOC-SBU-SBRT panel review
P50
Q26801000-272B9744-08F0-40B2-B321-DEC7DFF31B96Q26822395-0E1CB072-950F-4B91-8B5F-B8C49E1A89BDQ26863665-B7EA92D7-5ED6-441E-BB9A-924406C0FD95Q33558630-847E0681-3CB3-4FDA-B0D2-2A8681AA1E25Q36273993-9DDA2939-10B1-49E7-9D82-6EFF51100CDDQ37213101-3EEA9B95-2703-4B3F-B351-96FABA2061F3Q38036613-EB9BD2B2-43FB-4633-88A5-F472A08C3293Q38181898-AE21A67C-97EF-445F-9643-A3C1F7CB67B2Q38267215-9BDC6448-762A-4224-84E4-387682D86843Q38413430-871CAE98-61C2-4565-89DF-5C7AE5C277B1Q38487996-9F1426EB-AE19-4D92-965B-C80729D1872FQ91640748-C4912D83-950E-4E62-AD9E-5AFABA097B18
P50
description
researcher ORCID ID = 0000-0002-3038-3933
@en
wetenschapper
@nl
name
André Deeke Sasse
@ast
André Deeke Sasse
@en
André Deeke Sasse
@es
André Deeke Sasse
@nl
type
label
André Deeke Sasse
@ast
André Deeke Sasse
@en
André Deeke Sasse
@es
André Deeke Sasse
@nl
altLabel
Andre Deeke Sasse
@en
prefLabel
André Deeke Sasse
@ast
André Deeke Sasse
@en
André Deeke Sasse
@es
André Deeke Sasse
@nl
P106
P1153
12140803700
P31
P496
0000-0002-3038-3933